Long‐term outcomes of 176 patients with X‐linked hyper‐IgM syndrome treated with or without hematopoietic cell transplantation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaci.2016.07.039PMID 27697500PMCID PMC5374029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.

  2016cited by this paper
• Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan.

  2015cited by this paper
• Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience

  2015cited by this paper
• Hematopoietic stem cell transplant for hyper‐IgM syndrome due to CD40L defects: A single‐center experience

  2015cited by this paper
• Transplantation Outcomes for Severe Combined Immunodeficiency 2000–2009

  2015cited by this paper
• Clinical Features and Genetic Analysis of 20 Chinese Patients with X-Linked Hyper-IgM Syndrome

  2014cited by this paper
• Transplantation outcomes for severe combined immunodeficiency, 2000-2009.

  2014cited by this paper
• X-linked hyper IgM syndrome: clinical, immunological and molecular features in patients from India.

  2014cited by this paper
• First Report of the Hyper-IgM Syndrome Registry of the Latin American Society for Immunodeficiencies: Novel Mutations, Unique Infections, and Outcomes

  2014cited by this paper
• Clinical Features and Genetic Analysis of Taiwanese Patients With the Hyper IgM Syndrome Phenotype

  2013cited by this paper
• Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation.

  2013cited by this paper
• Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.

  2011cited by this paper
• Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?

  2010cited by this paper
• Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support

  2009cited by this paper
• Stem cell transplantation in primary immunodeficiency disease patients

  2007cited by this paper
• Defects of class-switch recombination.

  2006cited by this paper
• X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients

  2006cited by this paper
• Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team

  2006cited by this paper
• Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction

  2006cited by this paper
• The Hyper IgM Syndrome—An Evolving Story

  2004cited by this paper
• Acute myeloid leukemia

  2004cited by this paper
• Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathy.

  2004cited by this paper
• Allogeneic hematopoietic stem cell transplantation for seven children with X‐linked hyper‐IgM syndrome: A single center experience

  2004cited by this paper
• Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002.

  2003cited by this paper
• Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99.

  2003cited by this paper
• The X-Linked Hyper-IgM Syndrome: Clinical and Immunologic Features of 79 Patients

  2003cited by this paper
• Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment.

  2002cited by this paper
• Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

  2002cited by this paper
• Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.

  2001cited by this paper
• Bone marrow transplantation for CD40 ligand deficiency: a single centre experience

  2001cited by this paper
• Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome.

  2001cited by this paper
• The Role of CD40-CD154 Interactions in the Regulation of Cell Mediated Immunity

  2000cited by this paper
• Correction of the hyper-IgM syndrome after liver and bone marrow transplantation.

  2000cited by this paper
• Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome.

  1999cited by this paper
• Bone marrow transplantation as treatment for X-linked immunodeficiency with hyper-IgM

  1998cited by this paper
• Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome.

  1998cited by this paper
• Clinical spectrum of X-linked hyper-IgM syndrome.

  1997cited by this paper
• Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.

  1995cited by this paper
• Correction of X-Linked Hyper-IgM Syndrome by Allogeneic Bone Marrow Transplantation

  1995cited by this paper
• The role of gp39 (CD40L) in immunity.

  1995cited by this paper
• CD40 LIGAND MUTATIONS IN X-LINKED IMMUNODEFICIENCY WITH HYPER-IgM

  1994cited by this paper
• Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review.

  1994cited by this paper
• Activation of human dendritic cells through CD40 cross-linking

  1994cited by this paper
• The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

  1993cited by this paper
• Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM.

  1993cited by this paper
• Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

  1993cited by this paper
• CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome

  1993cited by this paper
• CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

  1993cited by this paper
• Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT.

  1992cited by this paper
• TPN: total parenteral nutrition.

  1988cited by this paper
• X-linked immunodeficiency with hyperimmunoglobulinemia M appears to be linked to the DXS42 restriction fragment length polymorphism locus

  1987cited by this paper
• Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M.

  1986cited by this paper
• Human malignant T cells capable of inducing an immunoglobulin class switch

  1985cited by this paper
• Hyper IgM immunodeficiency. A primary dysfunction of B lymphocyte isotype switching.

  1983cited by this paper
• Meeting report of the Second International Workshop on Primary Immunodeficiency Disease in Man held in St. Petersburg, Florida, February, 1973.

  1974cited by this paper
• [An example of atypical agammaglobulinemia (a case of severe hypogammaglobulinemia with increase of the beta-2 macroglobulin].

  1961cited by this paper
• Recurrent bacterial infections and dysgamma-globulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Report of two cases.

  1961cited by this paper
• RECURRENT BACTERIAL INFECTIONS AND DYSGAMMAGLOBULINEMIA: DEFICIENCY OF 7S GAMMA-GLOBULINS IN THE PRESENCE OF ELEVATED 19S GAMMA-GLOBULINS

  1961influential reference

• Case Report: CD40LG Arg203Ile variant underlies atypical phenotype of X-linked hyper IgM syndrome

  2025cites this paper
• Immunologic evaluation by a pediatric pulmonologist.

  2025cites this paper
• Recurrent Talaromyces Marneffei Infection Revealing X-Linked Hyper IgM Syndrome in an HIV-Negative Infant: A Diagnostic and Therapeutic Challenge

  2025cites this paper
• CD40 ligand: the essential link in B/T cell collaboration and immune activation.

  2025cites this paper
• Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review

  2024cites this paper
• DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome

  2024cites this paper
• Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis

  2024cites this paper
• Rare inborn error of immunity presenting as acute respiratory failure

  2024cites this paper
• Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacy

  2024cites this paper
• What a Clinician Needs to Know about Genome Editing: Status and Opportunities for Inborn Errors of Immunity.

  2024cites this paper
• Correcting inborn errors of immunity: From viral mediated gene addition to gene editing

  2023cites this paper
• Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo

  2023cites this paper
• Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T‐cells for the treatment of Hyper IgM1

  2023cites this paper
• Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency

  2023cites this paper
• Advanced computational analysis of CD40LG variants in atypical X-linked hyper-IgM syndrome.

  2023cites this paper
• Clinical Aspects of B Cell Immunodeficiencies: The Past, the Present and the Future

  2022cites this paper
• [Clinical effect of allogeneic hematopoietic stem cell transplantation in children with hyper-IgM syndrome].

  2022cites this paper
• Gene Edited T Cell Therapies for Inborn Errors of Immunity

  2022cites this paper
• Conditioning regimens for inborn errors of immunity: current perspectives and future strategies

  2022cites this paper
• Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature

  2022cites this paper
• HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh

  2022cites this paper
• Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network

  2022cites this paper
• Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency: Data from the USIDNET Registry.

  2022cites this paper
• Hematopoietic Cell Transplant for CD40 Ligand Deficiency—Comparing Busulfan Versus Treosulfan

  2022cites this paper
• Respiratory infections in X-linked hyper-IgM syndrome with CD40LG mutation: a case series of seven children in China

  2022cites this paper
• How I Treat Primary Immune Deficiencies with Hematopoietic Stem Cell Transplantation

  2022cites this paper
• CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics

  2022cites this paper
• Genes as Medicine: The Development of Gene Therapies for Inborn Errors of Immunity.

  2022cites this paper
• Class-Switch Defects

  2021cites this paper
• CD40LG mutations in Vietnamese patients with X‐linked hyper‐IgM syndrome; catastrophic anti‐phospholipid syndrome as a new complication

  2021influential citation
• CD40L modulates transcriptional signatures of neutrophils in the bone marrow associated with development and trafficking

  2021cites this paper
• Identi cation of genetic sequence variations associated with the pathogenesis of X-linked hyper-IgM syndrome

  2021cites this paper
• Human Primary Immunodeficiencies

  2021cites this paper
• Combined Immunodeficiencies

  2021cites this paper
• Combined T and B Lymphocyte Deficiencies

  2021cites this paper
• Immunodeficiencies affecting cellular and humoral immunity

  2021cites this paper
• Mitochondrial DNA insert into CD40 ligand gene‐associated X‐linked hyper‐IgM syndrome

  2021cites this paper
• Imaging Features of Primary Immunodeficiency Disorders.

  2021cites this paper
• Immunodeficiency Disorders Resulting in Malabsorption

  2021cites this paper
• Infectious Complications Predict Premature CD8+ T-cell Senescence in CD40 Ligand-Deficient Patients

  2021cites this paper
• Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome

  2021cites this paper
• Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline

  2020cites this paper
• Gene Therapy for Primary Immunodeficiency

  2020cites this paper
• Class switch recombination defects: impact on b cell maturation and antibody responses.

  2020cites this paper
• Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

  2020influential citation
• Class switch recombination defects

  2020cites this paper
• A Novel CD40L Mutation Associated with X-Linked Hyper IgM Syndrome in a Chinese Family

  2020cites this paper
• The Importance of Primary Immune Deficiency Registries: The United States Immunodeficiency Network Registry.

  2020cites this paper
• Hematopoietic stem cell transplantation in CD40 ligand deficiency: A single-center experience.

  2020cites this paper
• Hematopoietic stem cell transplantation for primary immune deficiencies

  2020cites this paper
• Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT

  2020cites this paper
• Gingivitis and Recurrent Tonsillitis

  2019cites this paper
• The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management.

  2019cites this paper
• Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.

  2019cites this paper
• Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.

  2019cites this paper
• CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives

  2019cites this paper
• Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome.

  2019cites this paper
• Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant

  2019cites this paper
• Hematopoietic Stem Cell Transplantation Beyond Severe Combined Immunodeficiency: Seeking a Cure for Primary Immunodeficiency.

  2019cites this paper
• Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases.

  2019cites this paper
• Chronic Cholangiopathy Associated with Primary Immune Deficiencies Can Be Resolved by Effective Hematopoietic Stem Cell Transplantation.

  2019cites this paper
• Pulmonary Manifestations of Combined T- and B-Cell Immunodeficiencies

  2019cites this paper
• Primary Immunodeficiency and the Gut.

  2019cites this paper
• Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in Iran

  2019cites this paper
• Clinical, genetic and immunological characteristics of 40 Chinese patients with CD40 ligand deficiency

  2019cites this paper
• Respiratory Complications in Patients with Hyper IgM Syndrome

  2019cites this paper
• Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives

  2019cites this paper
• Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation

  2019cites this paper
• Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies

  2019cites this paper
• Novel nonsense IL-12Rβ1 mutation associated with recurrent tuberculosis

  2019cites this paper
• X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene

  2019cites this paper
• Recurrent Infections and CNS Vasculitis

  2019cites this paper
• Recurrent Infections, Enteropathy and Granulomatous Lung Disease

  2019cites this paper
• Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.

  2019influential citation
• X-Linked Hyper-IgM Syndrome: CD40Ligand Deficiency (OMIM # 308230)

  2019cites this paper
• The experience of hematopoietic stem cell transplantation in primary immunodeficiencies in the Russian Children's Clinical Hospital

  2019cites this paper
• CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN‐&ggr;

  2018cites this paper
• Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.

  2018cites this paper
• A Novel de Novo Mutation in the CD40 Ligand Gene in a Patient With a Mild X-Linked Hyper-IgM Phenotype Initially Diagnosed as CVID: New Aspects of Old Diseases

  2018cites this paper
• Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases

  2018cites this paper
• Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child With CD40 Ligand Deficiency and Cryptosporidium-Induced Liver Cirrhosis

  2018cites this paper
• Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes

  2018cites this paper
• Clinical considerations in the hematopoietic stem cell transplant management of primary immunodeficiencies

  2018cites this paper
• 50 Years Ago in The Journal of Pediatrics: Familial Granulocytopenia and Associated Immunoglobulin Abnormality: Report of 3 Cases in Young Brothers.

  2018cites this paper
• Multiomics strategy in clinical immunology aiding unsolved antibody deficiencies

  2018cites this paper
• Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy

  2018influential citation
• Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries

  2018cites this paper
• An X-Linked Hyper-IgM Patient Followed Successfully for 23 Years without Hematopoietic Stem Cell Transplantation

  2018cites this paper
• Posttransplant recipient‐derived CD4+T‐cell lymphoproliferative disease in X‐linked hyper‐IgM syndrome

  2018cites this paper
• Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis

  2018cites this paper
• Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects

  2018cites this paper
• Advances and highlights in primary immunodeficiencies in 2017

  2018cites this paper
• Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome

  2018cites this paper
• Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.

  2018cites this paper
• Dominant‐negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency

  2018cites this paper
• Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience

  2018cites this paper
• Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome.

  2018cites this paper
• A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept

  2018cites this paper
• Progressive severe B cell and NK cell deficiency with T cell senescence in adult CD40L deficiency.

  2018cites this paper
• Population Pharmacokinetics of Intravenous Busulfan in Japanese Pediatric Patients With Primary Immunodeficiency Diseases

  2018cites this paper